Andreas Meinitzer
Impact in
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 2%
- Stress Responses and Cortisol
Papers in
-
- Tryptophan and brain disorders 27
-
- Stress Responses and Cortisol 13
- Co-authors
- Winfried MärzStefan PilzChristiane DrechslerHarald ManggeAndreas TomaschitzSieglinde ZelzerDietmar EnkoBernhard O. Boehm
- Journals
- PLoS ONE (12 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (12 papers)Atherosclerosis (5 papers)Scientific Reports (5 papers)Clinica Chimica Acta (5 papers)
- Partner nations
- AustriaGermanyNetherlands
In The Last Decade
Andreas Meinitzer
195 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 134
- Biological Psychiatry 543
- Behavioral Neuroscience 265
- Nephrology 425
- Physiology 1.3k
- Cardiology and Cardiovascular Medicine 1.1k
Countries citing papers authored by Andreas Meinitzer
This map shows the geographic impact of Andreas Meinitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Meinitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Meinitzer more than expected).
Fields of papers citing papers by Andreas Meinitzer
This network shows the impact of papers produced by Andreas Meinitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Meinitzer. The network helps show where Andreas Meinitzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Meinitzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2021 | 15 | |
| 6 | 2018 | 11 | |
| 7 | 2017 | 8 | |
| 8 | 2016 | 38 | |
| 9 | Abstract 17385: Eplerenon Reduces Qtc Time Intervall in Primary Hyperparathyroidism | 2016 | 1 |
| 10 | 2016 | 89 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 17 | |
| 13 | 2012 | 21 | |
| 14 | 2012 | 40 | |
| 15 | 2011 | 61 | |
| 16 | 2011 | 3 | |
| 17 | 2009 | 6 | |
| 18 | 2009 | 22 | |
| 19 | 2005 | 12 | |
| 20 | 1997 | 78 |
About Andreas Meinitzer
Andreas Meinitzer is a scholar working on Biological Psychiatry, Behavioral Neuroscience, Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 203 papers that have together received 5.0k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (27 papers), Vitamin D Research Studies (25 papers), Hormonal Regulation and Hypertension (21 papers), Nitric Oxide and Endothelin Effects (18 papers), Diet and metabolism studies (16 papers), Vitamin C and Antioxidants Research (15 papers), Stress Responses and Cortisol (13 papers) and Blood Pressure and Hypertension Studies (12 papers). The work is most often cited by research in Biological Psychiatry (543 citations), Behavioral Neuroscience (265 citations), Nephrology (425 citations), Physiology (1.3k citations) and Cardiology and Cardiovascular Medicine (1.1k citations). Andreas Meinitzer has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Winfried März, Stefan Pilz, Christiane Drechsler, Harald Mangge, Andreas Tomaschitz, Sieglinde Zelzer, Dietmar Enko, Bernhard O. Boehm, Bernhard R. Winkelmann and Eberhard Ritz. Their work appears in journals such as PLoS ONE, Clinical Chemistry and Laboratory Medicine (CCLM), Atherosclerosis, Scientific Reports and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.